Drug Trial Radar · NCT02545504
Andecaliximab With mFOLFOX6 as First Line Treatment for Advanced Gastric or Gastroesophageal Junction Adenocarcinoma
Last checked: Nov 20, 2026Latest source record: May 26, 2020 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
432
Actual
Start
Oct 13, 2015
Primary completion
May 15, 2019
Study completion May 15, 2019
Sponsor
- Lead sponsor
- Gilead SciencesGilead Sciences (GILD)
- Sponsor type
- Industry
- First posted
- Sep 10, 2015
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The primary objective of this study is to compare the efficacy of andecaliximab (GS-5745) versus placebo in combination with modified fluorouracil (5-FU), leucovorin (LV), and oxaliplatin (OXA) (mFOLFOX6) as measured by overall survival.
Conditions
- Gastric Adenocarcinoma
Interventions
AndecaliximabDrug
800 mg administered intravenously on Days 1 and 15 of each 28-day treatment cycle
PlaceboDrug
Administered intravenously on Days 1 and 15 of each treatment cycle
LeucovorinDrug
Administered intravenously per standard of care on Days 1 and 15 of each treatment cycle
5-fluorouracilDrug
Administered intravenously per standard of care on Days 1 and 15 of each treatment cycle
OxaliplatinDrug
Administered intravenously per standard of care on Days 1 and 15 of each treatment cycle
Primary outcomes
What the sponsor says the trial is designed to measure.
- Overall Survival (OS)Time frame: Andecaliximab + mFOLFOX6 median follow-up at the time of final analysis: 19.43 months; Placebo + mFOLFOX6 median follow-up at the time of the final analysis: 19.45 months
Locations
134 sites in 16 countries. Site status is shown where the registry gives one.
Scripps Green Hospital
La Jolla, California
University of Southern California
Los Angeles, California
UCLA Jonsson Comprehensive Cancer Center
Los Angeles, California
Innovative Clinical Research Institute
Whittier, California
Cancer Center of Central Connecticut
Plainville, Connecticut
Omega Research Consultants LLC
DeBary, Florida
Edward Hospital & Health Services
Naperville, Illinois
Parkview Hospital
Fort Wayne, Indiana
Indiana University Goshen Center for Cancer Care
Goshen, Indiana
Ochsner Clinic Foundation
New Orleans, Louisiana
New England Cancer Specialists
Scarborough, Maine
Karamanos Cancer Institute
Detroit, Michigan
HCA Healthcare
Kansas City, Missouri
Carol G. Simon Cancer Center
Morristown, New Jersey
Regional Cancer Care Associates LLC - Sparta
Sparta, New Jersey
Weill Cornell Medical College - New York Presbyterian Hospital
New York, New York
University of Rochester
Rochester, New York
Duke Cancer Institute
Durham, North Carolina
Oncology Hematology Care, Inc.
Cincinnati, Ohio
The Ohio State Medical Center
Columbus, Ohio
Northwest Cancer Specialists
Portland, Oregon
Charleston Hematology Oncology Associates
Charleston, South Carolina
Prairie Lakes Health Care System INC
Watertown, South Dakota
Tennessee Oncology
Nashville, Tennessee
Center for Cancer Blood Disorders
Fort Worth, Texas
The University of Texas MD Anderson Cancer Center
Houston, Texas
Texas Oncology-Seton Williamson
Round Rock, Texas
Scott and White Memorial Hospital
Temple, Texas
Utah Cancer Specialists
Salt Lake City, Utah
Virginia Commonwealth University
Richmond, Virginia
Virginia Mason Seattle Main Clinic
Seattle, Washington
The Tweed Hospital
Tweed Heads, Australia
Sydney Adventist Hospital
Wahroonga, Australia
The Canberra Hospital
Garran, Australian Capital Territory, Australia
Chris O'Brien Lifehouse
Camperdown, New South Wales, Australia
The Crown Princess Mary Cancer Centre
Westmead, New South Wales, Australia
Princess Alexandra Hospital
Brisbane, Queensland, Australia
Ashford Cancer Centre
Kurralta Park, South Australia, Australia
Royal Hobart Hospital
Hobart, Tasmania, Australia
Epworth Healthcare
Richmond, Victoria, Australia
Showing 40 of 134 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.